Remove Clinical Outsourcing Remove Drugs Remove Marketing
article thumbnail

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

pharmaphorum

Parexel has been a champion of the concept for years, but while adoption was fairly slow pre-COVID, it has accelerated at a fast pace since the crisis, aided by the increasing willingness of regulators to accept decentralised trial data in marketing applications.

article thumbnail

Modernizing Pharmacovigilance Outsourcing

XTalks

Midsize and large companies often have an internal drug safety team and safety database, and work with vendors to scale and reduce pharmacovigilance costs. Cloud solutions provide greater transparency and collaboration between pharma companies and service providers or CROs for stronger alignment and partnerships.